Location History:
- Standford, CA (US) (2006)
- Stanford, CA (US) (2001 - 2010)
Company Filing History:
4 out of 25 
1 out of 5,324 
3 out of 832,966 Years Active: 2001-2010
Title: Edwin S. Lennox: Innovator in Triptolide Derivatives
Introduction
Edwin S. Lennox is a notable inventor based in Stanford, CA, who has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has focused on developing innovative compounds that have potential applications in immunosuppression, anti-inflammatory treatments, and cancer therapy.
Latest Patents
Lennox's latest patents include groundbreaking work on triptolide derivatives for the modulation of apoptosis and immunosuppression. These compounds, which are variously substituted carbonate and carbamate derivatives of triptolide, exhibit good aqueous solubility. They convert to biologically active compounds in vivo at a rate that can be modulated by varying the substitution on the prodrug. The prodrugs developed by Lennox are particularly useful as immunosuppressive, anti-inflammatory, and anticancer agents.
Career Highlights
Throughout his career, Edwin S. Lennox has worked with various organizations, including Pharmagenesis, Inc. His innovative research has led to advancements in the pharmaceutical industry, particularly in the development of new therapeutic agents.
Collaborations
Lennox has collaborated with notable professionals in his field, including John H. Musser and Glenn D. Rosen. These collaborations have contributed to the success of his research and the development of his patented compounds.
Conclusion
Edwin S. Lennox is a distinguished inventor whose work on triptolide derivatives has the potential to impact the fields of immunology and oncology significantly. His contributions continue to pave the way for new therapeutic options in medicine.